Advanced search
Publication Cover
Biotechnology & Biotechnological Equipment Volume 30, 2016 - Issue 1
Submit an article Journal homepage
1,008
Views
0
CrossRef citations to date
0
Altmetric
Articles; Medical Biotechnology

Experimental model to study co-infection of human immunodeficiency virus-type 1 (HIV-1IIIB) and influenza virus in cell culture

Radka ArgirovaDepartment of Virology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria;Correspondence[email protected]
View further author information
,
Raina NenovaSection of Pathology, Institute of Experimental Morphology, Pathology, Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, BulgariaView further author information
,
Dimitar IvanovSection of Pathology, Institute of Experimental Morphology, Pathology, Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, BulgariaView further author information
,
Petya Genova-KalouDepartment of Virology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria;View further author information
&
Sevda RalevaDepartment of Virology, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria;View further author information
Pages 100-105 | Received 09 Aug 2015, Accepted 03 Sep 2015, Published online: 07 Oct 2015

References

  • Wei X, Decker J, Wang S, et al. Antibody neutralization and escape by HIV-1. Nature. 2003;422:307–312.
  • McMichael A, Hanke T. HIV vaccines 1983–2003. Nat Med. 2003;9:874–880.
  • Lin G, Simmons G, Pohlmann S, et al. Differential N-linked glycosylation of human immunodeficiency virus and ebola virus glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol. 2003;77:1337–1346.
  • Hu H, Shioda T, Moriya C, et al. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J Virol. 1996;11:7462–7470.
  • Taverna M, Nguet T, Valentin C, et al. A Multi-mode chromatographic method for the comparison of the N-glycosylation of recombinant HIV envelope glycoprotein (gp160s-MN/LAI) purified by two different processes. J Biotechnol. 1999;68:37–48.
  • Stein B, Engleman E. Intracellular processing of the gp160 HIV-1 envelope precursor. J Biol Chem. 1990;265:2640–2649.
  • Gavazova R, Ivanov S, Ivanov D, et al. An experimental model for study of sialoglycoproteins of human immunodeficiency virus 1 epitope structures. Acta virol. 2005;49:75–81.
  • Stamatos N, Gomatos P, Cox J, et al. Desialylation of peripheral blood mononuclear cells promoted growth of HIV-1. Virology. 1997;228:123–131.
  • Stamatos N, Curreli S, Zella D, et al. Desialylation of glucoconjugates on the surface of monocytes activates the extracellular signal-related kinases ERK ½ and results in enhanced production of specific cytokines. J Leucoc Biol. 2004;75:307–313.
  • Nathanson N, Holmes KV. Cellular receptors and viral tropism. In: Nathanson N, editor. Viral pathogenesis and immunity. London: Academic Press; 2007. p. 30–32.
  • Air G, Laver W. The neuraminidase of Influenza Virus. Proteins. 1989;6:341–356.
  • Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
  • Ding Yuan Oh, Barr I, Mosse J, et al. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol. 2008;46:2189–2194.
  • Sun J, Barbeau B, Sato S, et al. Syncytium formation and HIV-1 replication are both accentuated by purified influenza and virus-associated neuraminidase. J Biol Chem. 2002;277:9825–9833.
  • Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
  • World Health Organization. CDC protocol of real time RTPCR for swine influenza A(H1N1). 2009. Available from: http://www.who.int/csr/resources/publications/swineflu/CDCrealtimeRTPCRprotocol_20090428.pdf
  • Mock D, Domurat F, Roberts N, et al. Macrophages are required for influenza virus infection of human lymphocytes. J Clin Invest. 1987;79:620–624.
  • Montefiori D, Robinson W Jr, Schuffman S, et al. Evaluation of antiviral drugs and neutralizing antibodies by a rapid and sensitive microtiter infection assay. J Clin Microbiol. 1988;26:231–235.
  • McCullers J, Bartmess K. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis. 2003;187:1000–1009.
  • Chang Y-C, Uchiyama S, Varki A, et al. Leukocyte inflammatory responses provoked by pneumococcal sialidase. mBio [Internet]. 2012;3(1):e00220–11. Available from: http://dx.doi.org/10.1128/mBio.00220-11
  • Schenkman S, Jiang M, Hart G, et al. A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells. Cell. 1991;65:1117–1125.
  • Landolfi N, Leone J, Womack J, et al. Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase. Immunogenetics. 1985;22:159–167.
  • Galvan M, Murali-Krishna K, Ming L, et al. Alterations in cell surface carbohydrates on T Cells from virally infected mice can distinguish effector/memory CD8+ T cells from naïve cells. J Immunol. 1998;161:641–648.
  • Lukong K, Seyrantepe V, Landry K, et al. Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. J Biol Chem. 2001;276:46172–46181.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.